Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association

TM Giglia, MP Massicotte, JS Tweddell, RJ Barst… - Circulation, 2013 - Am Heart Assoc
Thrombosis has long been recognized as a potentially lifethreatening complication in
children with congenital heart disease (CHD), children with acquired heart disease, and in …

Bivalirudin as an alternative to heparin for anticoagulation in infants and children

ML Buck - The Journal of Pediatric Pharmacology and …, 2015 - meridian.allenpress.com
Bivalirudin, a direct thrombin inhibitor, is a useful alternative to heparin for anticoagulation in
infants and children. It has been found to be effective in patients requiring treatment of …

Bivalirudin for pediatric procedural anticoagulation: a narrative review

KL Zaleski, JA DiNardo, VG Nasr - Anesthesia & Analgesia, 2019 - journals.lww.com
Abstract Bivalirudin (Angiomax; The Medicines Company, Parsippany, NJ), a direct thrombin
inhibitor, has found increasing utilization as a heparin alternative in the pediatric population …

Pediatric catheterization laboratory anticoagulation with bivalirudin

TJ Forbes, ZM Hijazi, G Young… - Catheterization and …, 2011 - Wiley Online Library
Background: Pediatric physicians regularly face the problem of uncertain procedural
anticoagulation in children, especially in neonates. We sought to evaluate the safety, plasma …

Heparin-induced thrombocytopenia in the pediatric population: a review of current literature

NH Vakil, AO Kanaan… - The Journal of Pediatric …, 2012 - meridian.allenpress.com
Heparin-induced thrombocytopenia is a rare and serious reaction to unfractionated heparin
and low-molecular-weight heparins in children. Quick recognition, discontinuation of …

Randomized controlled trial of heparin versus bivalirudin anticoagulation in acyanotic children undergoing open heart surgery

S Hasija, S Talwar, N Makhija, S Chauhan… - … of Cardiothoracic and …, 2018 - Elsevier
Objective To determine the safety and efficacy of bivalirudin as an anticoagulant for pediatric
open heart surgery (OHS) and to determine its appropriate dosage for this purpose. Design …

The use of bivalirudin in pediatric cardiac surgery and in the interventional cardiology suite

D Goswami, M DiGiusto, R Wadia, S Barnes… - Journal of cardiothoracic …, 2020 - Elsevier
Anticoagulation is an essential component for patients undergoing cardiopulmonary bypass
or extracorporeal membrane oxygenation and for those with ventricular assist devices …

Perioperative care in an adolescent patient with heparin-induced thrombocytopenia for placement of a cardiac assist device and heart transplantation: case report and …

M Kamata, R Sebastian, PI McConnell… - … Case Reports Journal, 2017 - Taylor & Francis
Heparin-induced thrombocytopenia (HIT) can cause life-threatening complications following
the administration of heparin. Discontinuation of all sources of heparin exposure and the use …

Heparin-induced thrombocytopenia in children

AF Klenner, A Greinacher - Heparin-induced thrombocytopenia, 2012 - taylorfrancis.com
Heparin-induced thrombocytopenia (HIT) can occur in children, with the potential for severe
venous and arterial thrombotic complications (Table 21.1). Unlike in adults, few data exist …

Shunt thrombosis in pediatric patients undergoing staged cardiac reconstruction for cyanotic congenital heart disease

U Mahat, S Ahuja, R Talati - Progress in Pediatric Cardiology, 2020 - Elsevier
Three stage cardiac reconstruction is a common surgical procedure performed in children
with complex cyanotic congenital heart diseases (CCHD) such as hypoplastic left heart …